Those 10 people are already at risk of poor health regardless of CKD. See, not everyone that smokes gets lung cancer. Promarker D sounds like a test not dissimilar to a hypothetical predictive test that determines who, from smokers, will get lung cancer. What's the point? I'm not poo pooing the technology and importance of the test, I'm ultimately questioning the economic value of having this knowledge in a healthcare environment. Indicators already exist based on current health and lifestyle choices. Even you suggest that because Diabetes is seen as high risk for CKD and you imagine most would be on preventative medicine and then question if doctors will order the PIQ test. Why waste the money if they're on preventatives already. Happy to keep drilling down on this so I can be convinced. Cheers
PIQ Price at posting:
22.0¢ Sentiment: Hold Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)